Unraveling the Mystery of Delivery of Medical Device Trials in the Asia-Pacific

Publish Date:
March 7, 2013
D. Lee Spurgin Jr., PhD, and Nitin Jain

There are many reasons why the Asia-Pacific region is desirable for medical device trials, including that outsourcing in Asia can reduce the cost of trials by 50 percent or more, and that generally less complicated regulatory regimes often mean faster approval timelines. Downsides vary and range from language and cultural difficulties to differences in regulatory procedures for medical devices. In this helpful video, Lee Spurgin and Nitin Jain compare the pros and cons of conducting trials in different areas of the region including China, Japan, South Korea, Philippines, Taiwan, Singapore, Malaysia, Thailand and Australia/New Zealand.

File size: 1.33GB | Format: MP4 | Length: 33.50MINS

Depending on your operating system and type of Web browser the files may take a long time to download.